Internal Medicine, Gastroenterology · Boston, MA
NPI
1427048503
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
55 Fruit St, Gastroenterology Associates Blk 4
Boston, MA, 02114
Phone (617) 726-3505
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
1,267 services
Medicare patients, 2024
688
Average age 73
Drug cost, 2024
$629K
3,187 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barbara J Nath was code 99214 (office e&m - established), 220 times for 182 patients. In total Barbara J Nath billed 1,267 services in 43 codes, and Medicare paid $103K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 220 | 182 | $75.57 | $17K |
| 99215 Office E&M - Established | Facility | 154 | 144 | $111.74 | $17K |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 142 | 137 | $4.57 | $648 |
| 99231 Hospital E&M - Subsequent | Facility | 82 | 52 | $41.17 | $3,376 |
| 45380 Lower GI Endoscopy - Other | Facility | 60 | 60 | $90.43 | $5,426 |
| 99214 Office E&M - Established | Office | 60 | 51 | $105.29 | $6,317 |
| 99443 Telephone Services | Facility | 57 | 46 | $78.43 | $4,471 |
| 99213 Office E&M - Established | Office | 56 | 47 | $74.27 | $4,159 |
| 45385 Colonoscopy - Lesion Removal | Facility | 54 | 54 | $217.74 | $12K |
| 43239 Upper GI Endoscopy | Facility | 50 | 50 | $86.08 | $4,304 |
| 99213 Office E&M - Established | Facility | 38 | 34 | $50.56 | $1,921 |
| 91122 Test - Miscellaneous | Facility | 29 | 29 | $67.47 | $1,957 |
| 91120 Test - Miscellaneous | Facility | 29 | 29 | $36.52 | $1,059 |
| 99221 Hospital E&M - Initial | Facility | 24 | 24 | $68.83 | $1,652 |
| 43235 Upper GI Endoscopy | Facility | 24 | 24 | $88.14 | $2,115 |
By year: 2022 $106K for 1,281 services; 2023 $99K for 1,244 services; 2024 $103K for 1,267 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82272 Immunoassay | 22 | 22 | $4.23 | $92.98 |
Medicare prescription drug claims, 2024
In 2024, the drug Barbara J Nath prescribed most often to Medicare patients was Omeprazole, with 313 prescriptions and refills. In total Barbara J Nath wrote 3,187 Medicare prescriptions that cost $629K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 313 | 796 | 109 | $7,240 |
| Famotidine Generic | 221 | 589 | 78 | $4,376 |
| Gabapentin Generic | 146 | 318 | 48 | $2,670 |
| Linzess Linaclotide | 121 | 236 | 30 | $126K |
| Atorvastatin Calcium Generic | 117 | 323 | 28 | $1,530 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 112 | 112 | 109 | $1,586 |
| Lisinopril Generic | 96 | 252 | 23 | $859 |
| Motegrity Prucalopride Succinate | 91 | 181 | 23 | $97K |
| Hydrochlorothiazide Generic | 83 | 212 | 21 | $506 |
| Levothyroxine Sodium Generic | 77 | 176 | 16 | $658 |
| Pantoprazole Sodium Generic | 76 | 174 | 20 | $1,789 |
| Amlodipine Besylate Generic | 67 | 173 | 15 | $500 |
| Metoclopramide Hcl Generic | 65 | 84 | 20 | $1,264 |
| Esomeprazole Magnesium Generic | 64 | 141 | 15 | $5,034 |
| Nortriptyline Hcl Generic | 57 | 151 | 20 | $1,903 |
Brand drugs: - claims; generic drugs: 2,701 claims; opioid claims: 15.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Barbara J Nath were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.